Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma

Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer for which no early diagnostic method is available. The immune surveillance hypothesis suggests that the immune system plays crucial roles in tumor development and progression. We validated a PDAC-specific biomarker derived from peripher...

Full description

Bibliographic Details
Main Authors: Sung-Ill Jang, Jae-Hee Cho, So-Young Kim, In-Young Hong, Joon-Seong Park, Hye-Sun Lee, Goeun Park, Jong-Kyoung Kim, Hyung-Keun Lee, Dong-Ki Lee
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
pancreatic ductal adenocarcinoma
interleukin-7 receptor
cytokine
diagnosis
Online Access:https://www.mdpi.com/2072-6694/14/3/853

Internet

https://www.mdpi.com/2072-6694/14/3/853

Similar Items